CSIMarket
 


Organogenesis Holdings Inc   (ORGO)
Other Ticker:  
 

Cumulative Organogenesis Holdings Inc 's Quick Ratio for Trailing Twelve Months Period

ORGO's Quick Ratio for Trailing Twelve Months Period and Cash & cash equivalent, Current Liabilities growth


Select the Comparisons : Select the Ratio:

ORGO Quick Ratio for Trailing Twelve Months Period

(Sep 30 2023)
III. Quarter
(Jun 30 2023)
II. Quarter
(Mar 31 2023)
I. Quarter
(Dec 31 2022)
IV. Quarter
(Sep 30 2022)
III. Quarter
Y / Y Current Liabilities Growth -8.73 % -16.75 % -54.01 % -8.51 % 10.21 %
Y / Y Cash & cash equivalent Growth -8.41 % -20.81 % -17.8 % -10.05 % 4.9 %
Quick Ratio for Trailing Twelve Months Period 1.43 1.42 1.43 1.31 1.31
Total Ranking # 1226 # 1366 # 1474 # 1746 # 1753
Seq. Current Liabilities Growth 10.93 % 107.98 % -52.92 % -15.96 % 1.18 %
Seq. Cash & cash equivalent Growth 10.47 % 0.25 % -13.45 % -4.45 % -4.48 %


Quick Ratio for Trailing Twelve Months Period Comment for 12 Months ending at Sep 30 2023
On the trailing twelve months basis Current Liabilities decreased faster than Organogenesis Holdings Inc 's average Cash & cash equivalent, this led to increase in in Organogenesis Holdings Inc 's Quick Ratio for Trailing Twelve Months Period to 1.43, Quick Ratio for Trailing Twelve Months Period remained below Organogenesis Holdings Inc average.
Quick Ratio for Trailing Twelve Months Period is the average cumulative value over the last four quarters.

Among companies operatig within Major Pharmaceutical Preparations industry 357 other companies have achieved higher Quick Ratio for Trailing Twelve Months Period than Organogenesis Holdings Inc . While overall ranking remained unchanged compare to previous quarter at no. .

What is Quick Ratio?
Learn more about ORGO
Quick Ratio ORGO in the most recent quarter
Quick Ratio for Trailing Twelve Months Period Company Ranking
Within: No.
Industry # 358
Sector # 652
S&P 500 # 1237


Quick Ratio for Trailing Twelve Months Period Statistics
High Average Low
1.33 0.77 0.01
(Jun 30 2022)   (Sep 30 2018)




Companies with similar average Quick Ratio for Trailing Twelve Months Period for 12 months ending Sep 30 2023, within Major Pharmaceutical Preparations Industry Quick Ratio for Trailing Twelve Months Period
Mirum Pharmaceuticals Inc   3.91 
Immunogen inc   3.88 
Arvinas Inc   3.88 
Kiniksa Pharmaceuticals ltd   3.86 
Proqr Therapeutics N v   3.86 
Alpine Immune Sciences Inc   3.81 
Travere Therapeutics Inc   3.80 
Acurx Pharmaceuticals inc   3.79 
Theriva Biologics inc   3.73 
Puretech Health Plc  3.72 
Y mabs Therapeutics inc   3.71 
Genelux Corporation  3.71 
Monopar Therapeutics Inc   3.70 
Karyopharm Therapeutics Inc   3.69 
Liminal Biosciences Inc   3.68 
Immunome Inc  3.65 
Mustang Bio inc   3.64 
Gt Biopharma Inc   3.62 
Apellis Pharmaceuticals Inc   3.62 
Siga Technologies Inc  3.61 
Alterity Therapeutics Limited  3.60 
Vyne Therapeutics Inc   3.59 
Calithera Biosciences Inc   3.58 
Inmed Pharmaceuticals Inc   3.58 
Vertex Pharmaceuticals Inc  3.55 
Harmony Biosciences Holdings inc   3.50 
Pharming Group N v   3.47 
Edesa Biotech Inc   3.42 
Enveric Biosciences Inc   3.40 
Nextcure Inc   3.38 




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com